Skip to main content

08.05.2024 | Commentary

Navigating the “Psychedelic Renaissance”: From Research to Reality

verfasst von: Doris Payer, Sukhpreet Klaire, Dominique Morisano, Mary Bartram, Monnica Williams, Brian Rush

Erschienen in: International Journal of Mental Health and Addiction

Einloggen, um Zugang zu erhalten

Abstract

The field of psychedelics is in an important era, with a significant focus on the potential role of psychedelic compounds in the treatment of mental health and substance use disorders. In 2022, a scientific research conference was held in Toronto to bring together stakeholders from a variety of disciplines and to promote dialogue and collaboration. This Special Issue includes 8 papers based on presentations from the conference, which showcase the breadth of topics that were brought forward. Included are both quantitative and qualitative works, as well as two letters to the editors which further advance these important conversations. These articles not only present the current state of research into psychedelics, but also present viewpoints about their impacts on underrepresented communities, the need to recognize the history of these compounds that extends beyond this new Western “renaissance,” and the complexities of integrating psychedelics into mainstream medicine. This Special Issue serves as both an exploration of a much-discussed topic and a reminder that collaboration can advance the field in order to harness its potential impact.
Fußnoten
1
For a list of organizing and advisory group members, see https://​fromresearchtore​ality.​com/​about/​
 
Literatur
Zurück zum Zitat Boehnke, K. F., Kruger, D. J., & Lucas, P. (2024). Changed substance use after psychedelic experiences among individuals in Canada. International Journal of Mental Health and Addiction (in press). Boehnke, K. F., Kruger, D. J., & Lucas, P. (2024). Changed substance use after psychedelic experiences among individuals in Canada. International Journal of Mental Health and Addiction (in press).
Zurück zum Zitat Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411. Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411.
Zurück zum Zitat George, D. R., Hanson, R., Wilkinson, D., & Garcia-Romeu, A. (2022). Ancient roots of today’s emerging Renaissance in psychedelic medicine. Culture, Medicine and Psychiatry, 46(4), 890–903.CrossRefPubMed George, D. R., Hanson, R., Wilkinson, D., & Garcia-Romeu, A. (2022). Ancient roots of today’s emerging Renaissance in psychedelic medicine. Culture, Medicine and Psychiatry, 46(4), 890–903.CrossRefPubMed
Zurück zum Zitat Hadar, A., David, J., Shalit, N., Roseman, L., Gross, R., Sessa, B., & Lev-Ran, S. (2023). The psychedelic Renaissance in clinical research: A bibliometric analysis of three decades of human studies with psychedelics. Journal of Psychoactive Drugs, 55(1), 1–10.CrossRefPubMed Hadar, A., David, J., Shalit, N., Roseman, L., Gross, R., Sessa, B., & Lev-Ran, S. (2023). The psychedelic Renaissance in clinical research: A bibliometric analysis of three decades of human studies with psychedelics. Journal of Psychoactive Drugs, 55(1), 1–10.CrossRefPubMed
Zurück zum Zitat Hall, W. (2022). Why was early therapeutic research on psychedelic drugs abandoned? Psychological Medicine, 52(1), 26–31.CrossRefPubMed Hall, W. (2022). Why was early therapeutic research on psychedelic drugs abandoned? Psychological Medicine, 52(1), 26–31.CrossRefPubMed
Zurück zum Zitat Kryszajtys, D. T., Bender, J. L., Rush, B., & Strike, C. J. (2024). Decision-making around psychedelics for depression and anxiety: A model based on online discussions. International Journal of Mental Health and Addiction (in press). Kryszajtys, D. T., Bender, J. L., Rush, B., & Strike, C. J. (2024). Decision-making around psychedelics for depression and anxiety: A model based on online discussions. International Journal of Mental Health and Addiction (in press).
Zurück zum Zitat La Torre, J. T., Mahammadli, M., Faber, S., Greenway, K., & Williams, M. T. (2024). Expert opinion on psychedelic-assisted psychotherapy for people with psychosis. International Journal of Mental Health and Addiction (in press). La Torre, J. T., Mahammadli, M., Faber, S., Greenway, K., & Williams, M. T. (2024). Expert opinion on psychedelic-assisted psychotherapy for people with psychosis. International Journal of Mental Health and Addiction (in press).
Zurück zum Zitat MacIntyre, M. M. (2024). Letter to the editor. International Journal of Mental Health and Addiction (in press). MacIntyre, M. M. (2024). Letter to the editor. International Journal of Mental Health and Addiction (in press).
Zurück zum Zitat Marcus, O., & Dakwar, E. (2024). Paradigm lost: Towards an evidence-based ontology in psychedelic medicine? International Journal of Mental Health and Addiction (in press). Marcus, O., & Dakwar, E. (2024). Paradigm lost: Towards an evidence-based ontology in psychedelic medicine? International Journal of Mental Health and Addiction (in press).
Zurück zum Zitat Schenberg, E. E. (2018). Psychedelic-assisted psychotherapy: A paradigm shift in psychiatric research and development. Frontiers in Pharmacology, 9, 323606.CrossRef Schenberg, E. E. (2018). Psychedelic-assisted psychotherapy: A paradigm shift in psychiatric research and development. Frontiers in Pharmacology, 9, 323606.CrossRef
Zurück zum Zitat Seal, H. (2024). Critique of “changed substance use after psychedelic experiences among individuals in Canada”. International Journal of Mental Health and Addiction (in press). Seal, H. (2024). Critique of “changed substance use after psychedelic experiences among individuals in Canada”. International Journal of Mental Health and Addiction (in press).
Zurück zum Zitat Weiss, B., Roseman, L., Giribaldi, B., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D. (2024). Unique psychological mechanisms underlying psilocybin therapy versus escitalopram treatment in the treatment of major depressive disorder. International Journal of Mental Health and Addiction (in press). https://doi.org/10.1007/s11469-024-01253-9 Weiss, B., Roseman, L., Giribaldi, B., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D. (2024). Unique psychological mechanisms underlying psilocybin therapy versus escitalopram treatment in the treatment of major depressive disorder. International Journal of Mental Health and Addiction (in press). https://​doi.​org/​10.​1007/​s11469-024-01253-9
Zurück zum Zitat Williams, M. T., Cabral, V., & Faber, S. C. (2024). Psychedelics and racial justice. International Journal of Mental Health and Addiction (in press). Williams, M. T., Cabral, V., & Faber, S. C. (2024). Psychedelics and racial justice. International Journal of Mental Health and Addiction (in press).
Zurück zum Zitat Yaden, D. B., Berghella, A. P., Hendricks, P. S., Yaden, M. E., Levine, M., Rohde, J. S., Nayak, S., Johnson, M. W., & Garcia-Romeu, A. (2024). IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models. Pharmacological Research, 199, 106998.CrossRefPubMed Yaden, D. B., Berghella, A. P., Hendricks, P. S., Yaden, M. E., Levine, M., Rohde, J. S., Nayak, S., Johnson, M. W., & Garcia-Romeu, A. (2024). IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models. Pharmacological Research, 199, 106998.CrossRefPubMed
Zurück zum Zitat Zare, M., & Williams, M. T. (2024). Muslim women and psychedelics: A look at the past, present, and future. International Journal of Mental Health and Addiction (in press). Zare, M., & Williams, M. T. (2024). Muslim women and psychedelics: A look at the past, present, and future. International Journal of Mental Health and Addiction (in press).
Metadaten
Titel
Navigating the “Psychedelic Renaissance”: From Research to Reality
verfasst von
Doris Payer
Sukhpreet Klaire
Dominique Morisano
Mary Bartram
Monnica Williams
Brian Rush
Publikationsdatum
08.05.2024
Verlag
Springer US
Erschienen in
International Journal of Mental Health and Addiction
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI
https://doi.org/10.1007/s11469-024-01288-y

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.